Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

被引:67
|
作者
Santosh, Baby [1 ]
Yadava, Pramod K. [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, Appl Mol Biol Lab, New Delhi 110067, India
关键词
IN-VITRO SELECTION; BREAST-CANCER CELLS; RNA-APTAMER; DNA APTAMERS; BINDING-SPECIFICITY; POTENTIAL TREATMENT; PEPTIDE APTAMERS; MALACHITE GREEN; BETA-CATENIN; MOLECULES;
D O I
10.1155/2014/540451
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic and therapeutic applications. Although use of nucleic acid aptamers as targeted therapeutics or mediators of targeted drug delivery is a relatively new avenue of research, one aptamer-based drug "Macugen" is FDA approved and a series of aptamer-based drugs are in clinical pipelines. The present review discusses the aspects of design, unique properties, applications, and development of different aptamers to aid in cancer diagnosis, prevention, and/or treatment under defined conditions.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
    Li, Long
    Xu, Shujuan
    Yan, He
    Li, Xiaowei
    Yazd, Hoda Safari
    Li, Xiang
    Huang, Tong
    Cui, Cheng
    Jiang, Jianhui
    Tan, Weihong
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (05) : 2221 - 2231
  • [2] Editorial: Nucleic acid-based aptamers in therapeutics and diagnostics
    Avino, Anna
    Fabrega, Carme
    Gargallo, Raimundo
    Mazzini, Stefania
    Riccardi, Claudia
    [J]. FRONTIERS IN CHEMISTRY, 2024, 11
  • [3] Nucleic acid therapeutics: a focus on the development of aptamers
    Jain, Swati
    Kaur, Jaskirat
    Prasad, Shivcharan
    Roy, Ipsita
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (03) : 255 - 274
  • [4] Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer's Disease Pathology
    Tannenberg, Rudi K.
    Al Shamaileh, Hadi
    Lauridsen, Lasse H.
    Kanwar, Jagat R.
    Dodd, Peter R.
    Veedu, Rakesh N.
    [J]. CURRENT ALZHEIMER RESEARCH, 2013, 10 (04) : 442 - 448
  • [5] Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
    Shigdar, Sarah
    Ward, Alister C.
    De, Abhijit
    Yang, Chaoyong J.
    Wei, Mingqian
    Duan, Wei
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (01) : 3 - 13
  • [6] Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics
    Becker, Richard C.
    Povsic, Thomas
    Cohen, Mauricio G.
    Rusconi, Christopher P.
    Sullenger, Bruce
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (03) : 586 - 595
  • [7] Aptamers in the Therapeutics and Diagnostics Pipelines
    Kaur, Harleen
    Bruno, John G.
    Kumar, Amit
    Sharma, Tarun Kumar
    [J]. THERANOSTICS, 2018, 8 (15): : 4016 - 4032
  • [8] Nucleic acid aptamers as tools and drugs: Recent developments
    Rimmele, M
    [J]. CHEMBIOCHEM, 2003, 4 (10) : 963 - 971
  • [9] Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
    Vorhies, John S.
    Nemunaitis, John J.
    [J]. BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 367 - 376
  • [10] Developing aptamers into tumor diagnostics and therapeutics
    Bruce A. Sullenger
    Bryan M. Clary
    [J]. 中国肿瘤生物治疗杂志, 2008, (04) : 301 - 304